Company Performance Metrics
Jeffry Weinhuff: Managing Partner- Garrett Hamontree: Principal
Visionary is a venture capital firm that invests in the most promising emerging ophthalmology companies in medical devices and pharmaceuticals.
With many breakthrough ophthalmic technologies and platforms on the horizon, Visionary Venture Fund was created to help these companies by contributing clinical expertise, commercialization know-how, and
growth capital. We work hand-in-hand with today's most promising ophthalmic technologies to create tomorrow's commercial blockbusters.
We're looking for visionary entrepreneurs, proven teams, and strong IP to create exciting ideas that address large unmet needs in ophthalmology in order to create market-leading businesses. We are a focused venture capital fund from round A to commercialization. Our target investments range from $500K to $5M in financing rounds ranging from $5M to $15MM. We seek to be lead investors and a partner of choice in our deals as we bring a strong KOL doctor partnership to the table.
Visionary’s fund performance net of fees is a 30% IIR, which places it in the top decile of US venture funds.
